Sonoma Pharmaceuticals (SNOA) Share-based Compensation (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Share-based Compensation of $135000.0 for Q1 2026, up 50.0% year-over-year from $90000.0 in Q1 2025, and up 11.57% quarter-over-quarter from $121000.0 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Share-based Compensation (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Share-based Compensation history runs 17 years deep, the most recent figure standing at $135000.0 for Q1 2026.
- In Q1 2026, Share-based Compensation rose 50.0% year-over-year to $135000.0; the TTM figure through Mar 2026 stood at $321000.0 (up 43.3% YoY), while the FY2026 annual figure was $255000.0, up 2.0% from the prior year.
- Share-based Compensation for Q1 2026 stood at $135000.0, up from $121000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $242000.0 in Q4 2022, with the low at $13000.0 in Q4 2024.
- The 5-year median for Share-based Compensation is $108000.0 (2022), against an average of $115176.5.
- The sharpest annual moves came in 2022 and 2024: Share-based Compensation surged 3500.0% in 2022, then plunged 90.71% in 2024.
- Sonoma Pharmaceuticals' Share-based Compensation stood at $242000.0 in 2022, then slumped by 42.15% to $140000.0 in 2023, then slumped by 90.71% to $13000.0 in 2024, then soared by 830.77% to $121000.0 in 2025, then increased by 11.57% to $135000.0 in 2026.
- Business Quant data shows SNOA's Share-based Compensation at $135000.0 in Q1 2026, $121000.0 in Q4 2025, and $39000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn | 58,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 58,000.00 |
| Jun 30, 2026 | 58,000.00 |
| Mar 31, 2026 | 135,000.00 |
| Mar 31, 2026 | 135,000.00 |
| Dec 31, 2025 | 121,000.00 |
| Dec 31, 2025 | 121,000.00 |
| Sep 30, 2025 | 39,000.00 |
| Sep 30, 2025 | 39,000.00 |
| Jun 30, 2025 | 57,000.00 |
| Jun 30, 2025 | 57,000.00 |
| Mar 31, 2025 | 90,000.00 |
| Mar 31, 2025 | 90,000.00 |
| Dec 31, 2024 | 13,000.00 |
| Dec 31, 2024 | 13,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 107,000.00 |
| Jun 30, 2024 | 107,000.00 |
| Mar 31, 2024 | 69,000.00 |
| Mar 31, 2024 | 69,000.00 |